QIAGEN reports results for fourth quarter and full-year 2019

QIAGEN launches FFPE and Liquid Biopsy PIK3CA diagnostics in Europe to enhance precision medicine in advanced breast cancer

QIAGEN launches Oncology Molecular Profiling Services in Europe

QIAGEN builds on global collaboration with Amgen for companion diagnostic development in non-small cell lung cancer

QIAGEN celebrates surpassing 2,500 cumulative placements of QIAsymphony 

QIAGEN’s QuantiFERON®-TB Gold Plus gains approval in Canada

QIAGEN unveils plans for next-generation digital PCR systems

QIAGEN to develop QuantiFERON®-TB Access as a new test for low-resource, high-burden regions in global fight against TB

QIAGEN launches QIAcube Connect – next-generation automation for sample processing in research labs

QIAGEN acquires N-of-One, expanding its clinical bioinformatics capabilities in molecular oncology decision support